Phd Nextcure Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phd nextcure inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phd Nextcure Inc Today - Breaking & Trending Today

NextCure Presents Preclinical Data for NC762 at American Association for Cancer Research (AACR) Annual Meeting 2021


Share:
BELTSVILLE, Md., April 10, 2021 (GLOBE NEWSWIRE) NextCure, Inc. (NASDAQ:NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today presented preclinical and investigational new drug (IND)-enabling data for NC762 at the American Association for Cancer Research (AACR) Annual Meeting 2021. NC762 is a humanized monoclonal antibody specific for B7-H4 and is being developed for the treatment of cancer.
The research presented by our team reinforces our confidence that NC762, our third program, is a novel immunomedicine with unique anti-tumor properties. We believe it has the potential to provide benefit in multiple oncology indications, particularly in cancers where high B7-H4 expression has been observed, such as breast, ovarian and lung cancers, said Michael Richman, NextCure s president and chief executive officer. We look forward to advan ....

United States , Michael Richman , Emily Wong Macdougall , Timothy Mayer , Exchange Commission , American Association For Cancer Research , Phd Nextcure Inc , Nextcure Inc , American Association , Cancer Research , Annual Meeting , Functional Characterization , Tumor Immune System , Private Securities Litigation Reform Act , Inquiries Timothy Mayer , Chief Operating Officer , Inquiries Emily Wong Macdougall , ஒன்றுபட்டது மாநிலங்களில் , மைக்கேல் பணக்காரன் , எமிலி வோங் மக்டூகல் , தீமோத்தேயு மேயர் , பரிமாற்றம் தரகு , அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி , அமெரிக்கன் சங்கம் , புற்றுநோய் ஆராய்ச்சி , ஆண்டு சந்தித்தல் ,